Download Files:
RGT-068A
SKU
HY-151805-Get quote
Category Reference compound
Tags Cancer, MALT1, Metabolic Enzyme/Protease;NF-κB
Products Details
Product Description
– RGT-068A is a potent, selective and oral bioavailable MALT1 inhibitor[1].
Web ID
– HY-151805
Shipping
– Room temperature
Molecular Formula
– C17H16ClN9O2
References
– [1]Feng S, et, al. Direct Construction of Chiral Ether via Highly Efficient Heck Reaction and N-Directed Asymmetric Hydrogenation for Large-Scale Synthesis of MALT1 Inhibitor RGT-068A. Org. Process Res. Dev. 2022.
CAS Number
– 2577171-33-4
Molecular Weight
– 413.82
SMILES
– CO[C@H](C1=C(C=NN2C=CN=C12)NC(NC3=CN=C(C(Cl)=C3)N4N=CC=N4)=O)C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– MALT1
Pathway
– Metabolic Enzyme/Protease;NF-κB
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.